Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres

J Drug Target. 2008 Aug;16(7):543-54. doi: 10.1080/10611860802228558.

Abstract

The ability of liposomes and microspheres to enhance the efficacy of a sub-unit antigen was investigated. Microspheres were optimised by testing a range of surfactants employed in the external aqueous phase of a water-in-oil-in-water (w/o/w) double emulsion solvent evaporation process for the preparation of microspheres--composed of poly(D,L-lactide-co-glycolide) and the immunological adjuvant dimethyl dioctadecyl ammonium bromide (DDA)--and then investigated with regard to the physico-chemical and immunological characteristics of the particles produced. The results demonstrate that this parameter can affect the physico-chemical characteristics of these systems and subsequently, has a substantial bearing on the level of immune response achieved, both humoral and cell mediated, when employed for the delivery of the sub-unit tuberculosis vaccine antigen Ag85B-ESAT-6. Moreover, the microsphere preparations investigated failed to initiate immune responses at the levels achieved with an adjuvant DDA-based liposome formulation (DDA-TDB), further substantiating the superior ability of liposomes as vaccine delivery systems.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Animals
  • Cell Proliferation
  • Cytokines / biosynthesis
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Liposomes*
  • Mice
  • Mice, Inbred BALB C
  • Microscopy, Electron, Scanning
  • Microspheres
  • Particle Size
  • Quaternary Ammonium Compounds / administration & dosage*
  • Vaccines / administration & dosage*

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Liposomes
  • Quaternary Ammonium Compounds
  • Vaccines
  • dimethyldioctadecylammonium